Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ArQule and Daiichi Sankyo complete patient recruitment in phase III tivantinib study

May 21, 2012

Promising results reported for first patients in phase I trial of VRX-007

May 21, 2012

Novel histone deacetylase inhibitors prepared by Georgia Tech Research Corp.

May 21, 2012

Sonic hedgehog pathway inhibitors disclosed by U.S. researchers

May 21, 2012

Spectrum Pharmaceuticals begins Zevalin/motexafin combination study

May 18, 2012

Ambit Biosciences and Teva receive IND clearance for CEP-32496

May 18, 2012

PCI Biotech enrolls first patient in phase II ENHANCE study of Amphinex

May 18, 2012

Novel isoflavones discovered at Nanjing University of Technology

May 18, 2012

Scientists at Antoxis disclose novel antioxidant compounds

May 18, 2012

Imipramine blue with doxorubicin improves survival in glioma model

May 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...